Long-term use of hydroxyurea can lead to cumulative toxicity, which may include chronic bone marrow suppression and an increased risk of secondary malignancies, particularly acute myeloid leukemia (AML). Regular monitoring and periodic dose adjustments are crucial to mitigate these risks.
